BIOTEST-SERUM-INSTITUTE GMBH – Trademark Portfolio

Entity Type: 03

BIOTEST-SERUM-INSTITUTE GMBH holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SERACLONE. The owner is based in FRANKFURT.

FLUGHAFENSTR

FRANKFURT , DE

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BIOTEST-SERUM-INSTITUTE GMBH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does BIOTEST-SERUM-INSTITUTE GMBH have?

BIOTEST-SERUM-INSTITUTE GMBH has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does BIOTEST-SERUM-INSTITUTE GMBH file in?

BIOTEST-SERUM-INSTITUTE GMBH files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are BIOTEST-SERUM-INSTITUTE GMBH's most well-known trademarks?

BIOTEST-SERUM-INSTITUTE GMBH's registered trademark portfolio includes well-known marks such as SERACLONE. These are among 1 currently registered trademark in the portfolio.

What is BIOTEST-SERUM-INSTITUTE GMBH's trademark registration success rate?

BIOTEST-SERUM-INSTITUTE GMBH has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.